A population-based risk algorithm for the development of diabetes: development and validation of the Diabetes Population Risk Tool (DPoRT)

Background National estimates of the upcoming diabetes epidemic are needed to understand the distribution of diabetes risk in the population and to inform health policy. Objective To create and validate a population-based risk prediction tool for incident diabetes using commonly collected national survey data. Methods With the use of a cohort design that links baseline risk factors to a validated population-based diabetes registry, a model (Diabetes Population Risk Tool (DPoRT)) was developed to predict 9-year risk for diabetes. The probability of developing diabetes was modelled using sex-specific Weibull survival functions for people >20 years of age without diabetes (N=19 861). The model was validated in two external cohorts in Ontario (N=26 465) and Manitoba (N=9899). Predictive accuracy and model performance were assessed by comparing observed diabetes rates with predicted estimates. Discrimination and calibration were measured using a C statistic and Hosmer–Lemeshow χ2 statistic (χ2H–L). Results Predictive factors included were body mass index, age, ethnicity, hypertension, immigrant status, smoking, education status and heart disease. DPoRT showed good discrimination (C=0.77–0.80) and calibration (χ2H–L <20) in both external validation cohorts. Conclusions This algorithm can be used to estimate diabetes incidence and quantify the effect of interventions using routinely collected survey data.

[1]  P. Metcalf,et al.  Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators. , 1996, Metabolism: clinical and experimental.

[2]  G. Berglund,et al.  Prediction of diabetes using ADA or WHO criteria in post-menopausal women: a 10-year follow-up study , 2000, Diabetologia.

[3]  Vern T. Farewell,et al.  A Study of Distributional Shape in Life Testing , 1977 .

[4]  R. Koopman,et al.  Impact of the population at risk of diabetes on projections of diabetes burden in the United States: an epidemic on the way , 2006, Diabetologia.

[5]  A. Astrup,et al.  Obesity : Preventing and managing the global epidemic , 2000 .

[6]  Julia A. Critchley,et al.  Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000 , 2004 .

[7]  Jaakko Tuomilehto,et al.  The diabetes risk score: a practical tool to predict type 2 diabetes risk. , 2003, Diabetes care.

[8]  H. Nawaz,et al.  Self-reported weight and height: implications for obesity research. , 2001, American journal of preventive medicine.

[9]  Peter Tanuseputro,et al.  Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study , 2006, BMJ : British Medical Journal.

[10]  David M Eddy,et al.  Validation of the archimedes diabetes model. , 2003, Diabetes care.

[11]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[12]  D G Altman,et al.  What do we mean by validating a prognostic model? , 2000, Statistics in medicine.

[13]  Ralph B D'Agostino,et al.  Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. , 2007, Archives of internal medicine.

[14]  K. Anderson,et al.  An updated coronary risk profile. A statement for health professionals. , 1991, Circulation.

[15]  H. Mantel,et al.  VARIANCE ESTIMATION FOR THE NATIONAL POPULATION HEALTH SURVEY , 2002 .

[16]  Stephen W. Sorensen,et al.  Lifetime risk for diabetes mellitus in the United States. , 2003, JAMA.

[17]  K. Anderson,et al.  New models for predicting cardiovascular events. , 1994, Journal of clinical epidemiology.

[18]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[19]  D. Manuel,et al.  Health-related quality of life and health-adjusted life expectancy of people with diabetes in Ontario, Canada, 1996-1997. , 2004, Diabetes care.

[20]  R. D'Agostino,et al.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. , 2001, JAMA.

[21]  Yves Béland,et al.  Canadian community health survey--methodological overview. , 2002, Health reports.

[22]  Arch G Mainous,et al.  A coronary heart disease risk score based on patient-reported information. , 2007, The American journal of cardiology.

[23]  P. Morrison,et al.  Suicide deaths and suicide attempts. , 2002, Health reports.

[24]  Ralph B D'Agostino,et al.  Risk Variable Clustering in the Insulin Resistance Syndrome: The Framingham Offspring Study , 1997, Diabetes.

[25]  R. DeFronzo,et al.  Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.

[26]  徐晶（译）.  基因科学与亲子鉴定——国际流行病与公众健康杂志J Epidemiol Community Health , 2005 .

[27]  Bootstrap Variance Estimation for Predicted Individual and Population-Average Risks , 2008 .

[28]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[29]  D. Hosmer,et al.  A comparison of goodness-of-fit tests for the logistic regression model. , 1997, Statistics in medicine.

[30]  S. Haffner,et al.  The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. , 2003, Diabetes care.

[31]  G. Campbell,et al.  Advances in statistical methodology for the evaluation of diagnostic and laboratory tests. , 1994, Statistics in medicine.

[32]  Ralph B D'Agostino,et al.  Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. , 2003, Diabetes.

[33]  M. Engelgau,et al.  A New and Simple Questionnaire to Identify People at Increased Risk for Undiagnosed Diabetes , 1995, Diabetes Care.

[34]  J. Hippisley-Cox,et al.  Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study , 2007, BMJ : British Medical Journal.

[35]  Janet E Hux,et al.  Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. , 2002, Diabetes care.

[36]  M. Pencina,et al.  Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation , 2004, Statistics in medicine.

[37]  M. Pepe,et al.  Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. , 2004, American journal of epidemiology.

[38]  Patrick Royston,et al.  Simplifying a prognostic model: a simulation study based on clinical data , 2002, Statistics in medicine.

[39]  Janet E Hux,et al.  Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based study , 2007, The Lancet.

[40]  L. Cardon,et al.  Clustering of hypertension, diabetes, and obesity in adult male twins: same genes or same environments? , 1994, American journal of human genetics.

[41]  L S Geiss,et al.  Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. , 2001, Diabetes care.

[42]  C. Ito,et al.  Prediction of diabetes mellitus (NIDDM). , 1996, Diabetes research and clinical practice.

[43]  K Lachowycz,et al.  Diabetes prevalence in England, 2001—estimates from an epidemiological model , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[44]  S. Haffner,et al.  Identification of Persons at High Risk for Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test? , 2002, Annals of Internal Medicine.

[45]  H. King,et al.  Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.